Nuveen’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.33M | Buy |
65,804
+388
| +0.6% | +$15.8K | ﹤0.01% | 2223 |
|
|
2025
Q4 | $2.66M | Sell |
65,416
-2,150
| -3% | -$93.5K | ﹤0.01% | 2172 |
|
|
2025
Q3 | $3.18M | Hold |
67,566
| – | – | ﹤0.01% | 2113 |
|
|
2025
Q2 | $3.52M | Sell |
67,566
-13,953
| -17% | -$766K | ﹤0.01% | 2052 |
|
|
2025
Q1 | $4.92M | Hold |
81,519
| – | – | ﹤0.01% | 1937 |
|
|
2024
Q4 | $5.58M | Sell |
81,519
-59,427
| -42% | -$4.14M | ﹤0.01% | 1934 |
|
|
2024
Q3 | $10.1M | Sell |
140,946
-92,552
| -40% | -$6.53M | ﹤0.01% | 1595 |
|
|
2024
Q2 | $16.2M | Buy |
233,498
+150,915
| +183% | +$11M | ﹤0.01% | 1267 |
|
|
2024
Q1 | $6.61M | Sell |
82,583
-1,006
| -1% | -$89.7K | ﹤0.01% | 1837 |
|
|
2023
Q4 | $9.15M | Buy |
83,589
+1,476
| +2% | +$153K | ﹤0.01% | 1641 |
|
|
2023
Q3 | $8.28M | Buy |
82,113
+628
| +0.8% | +$72.2K | ﹤0.01% | 1587 |
|
|
2023
Q2 | $11.1M | Buy |
81,485
+2,394
| +3% | +$292K | ﹤0.01% | 1453 |
|
|
2023
Q1 | $8.21M | Sell |
79,091
-1,568
| -2% | -$152K | ﹤0.01% | 1608 |
|
|
2022
Q4 | $7.15M | Sell |
80,659
-5,866
| -7% | -$487K | ﹤0.01% | 1707 |
|
|
2022
Q3 | $6.94M | Sell |
86,525
-79,971
| -48% | -$7.54M | ﹤0.01% | 1699 |
|
|
2022
Q2 | $15.9M | Sell |
166,496
-3,697
| -2% | -$444K | 0.01% | 1211 |
|
|
2022
Q1 | $24.4M | Sell |
170,193
-8,025
| -5% | -$1.12M | 0.01% | 1064 |
|
|
2021
Q4 | $25.3M | Buy |
178,218
+69,347
| +64% | +$9.82M | 0.01% | 1079 |
|
|
2021
Q3 | $14.2M | Sell |
108,871
-62,628
| -37% | -$8.19M | ﹤0.01% | 1527 |
|
|
2021
Q2 | $23.6M | Sell |
171,499
-38,738
| -18% | -$5.3M | 0.01% | 1237 |
|
|
2021
Q1 | $27.5M | Sell |
210,237
-103,416
| -33% | -$12.4M | 0.01% | 1089 |
|
|
2020
Q4 | $35.1M | Sell |
313,653
-23,863
| -7% | -$2.26M | 0.01% | 893 |
|
|
2020
Q3 | $26.6M | Sell |
337,516
-2,614
| -0.8% | -$213K | 0.01% | 902 |
|
|
2020
Q2 | $24.5M | Buy |
340,130
+33,775
| +11% | +$2.35M | 0.01% | 915 |
|
|
2020
Q1 | $17.5M | Buy |
306,355
+7,177
| +2% | +$662K | 0.01% | 971 |
|
|
2019
Q4 | $33.5M | Sell |
299,178
-8,497
| -3% | -$906K | 0.01% | 880 |
|
|
2019
Q3 | $29.6M | Buy |
307,675
+16,290
| +6% | +$1.53M | 0.01% | 929 |
|
|
2019
Q2 | $24.9M | Buy |
+291,385
| New | +$24M | 0.01% | 1040 |
|
|
2014
Q2 | – | Sell |
-16,973
| Closed | -$737K | – | 1609 |
|
|
2014
Q1 | $737K | Sell |
16,973
-16,339
| -49% | -$728K | ﹤0.01% | 1245 |
|
|
2013
Q4 | $1.42M | Buy |
33,312
+3,636
| +12% | +$138K | 0.01% | 933 |
|
|
2013
Q3 | $1.01M | Buy |
29,676
+145
| +0.5% | +$4.73K | 0.01% | 1104 |
|
|
2013
Q2 | $923K | Buy |
+29,531
| New | +$958K | 0.01% | 1068 |
|
Other funds holding CNMD
VPM
VCM
CB
Nuveen's CNMD Position: Q1 2026 in Review
Nuveen increased its CONMED (CNMD) stake by 0.59% in Q1 2026, buying an estimated $15.8K and bringing the position to 65,804 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.
Nuveen first reported a position in CNMD in Q2 2013 and has held it in 32 quarters since. The position peaked at $35.1M in Q4 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Nuveen held 65,804 shares of CONMED worth $2.33M as of Q1 2026.
- Nuveen bought 388 CONMED shares in Q1 2026, an estimated $15.8K.
- CONMED made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2223 holding.
- Nuveen first reported a position in CONMED in Q2 2013 and has held it in 32 quarters since.
- Nuveen's CONMED position peaked at $35.1M in Q4 2020.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.